Product
Help
Pricing
About
Jobs
Log in
Get started
Work
Add to collection
The New CXCR4 Inhibitor MDX-1338 Exerts Anti-Tumor Activity in Multiple Myeloma
HTML
Details
Locations
Year:
2011
Type:
article
Source:
Blood
DOI:
10.1182/blood.v118.21.1844.1844
Authors:
Aldo M Roccaro,
Antonio Sacco,
Michelle Kuhne,
AbdelKareem Azab,
Patricia Maiso,
Yong Zhang,
Yang Liu,
Feda Azab,
Ghayas C Issa,
Phong Quang,
Hai T Ngo,
Chin Pan,
Lew Choen,
Pina M Cardarelli,
Irene M. Ghobrial
show all 15
Institutions:
Harvard University,
Dana-Farber Cancer Institute,
Bristol-Myers Squibb (United States),
Bristol-Myers Squibb (United Kingdom)
Language:
English
Topic:
Multiple Myeloma Research and Treatments
Subfield:
Hematology
Field:
Medicine
Domain:
Health Sciences
SDG:
Good health and well-being
Open Access status:
closed
OpenAlex ID:
W2587777840
FWCI:
0.189
Cites:
Cited by:
2
Related to:
10